# Lineage Cell Therapeutics, Inc.: Form 8-K, filed Jan 27, 2025

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: 8-K
- Filed: 2025-01-27
- Accepted by EDGAR: Jan 27, 2025, 16:30 ET
- Period: 2025-01-27
- Accession: 0000950170-25-009227
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000095017025009227/lctx-20250127.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000095017025009227/

## Items reported

- Item 5.07: Shareholder vote results
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000095017025009227/lctx-20250127.htm

Filed Jan 27, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-009227. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.